These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9858949)

  • 1. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(5A):3621-8. PubMed ID: 9858949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(4A):2701-10. PubMed ID: 9703932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin.
    Takahashi N; Kawanishi-Tabata R; Haba A; Tabata M; Haruta Y; Tsai H; Seon BK
    Clin Cancer Res; 2001 Mar; 7(3):524-32. PubMed ID: 11297243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis and metastasis marker of human tumors.
    Seon BK; Takahashi N; Haba A; Matsuno F; Haruta Y; She XW; Harada N; Tsai H
    Rinsho Byori; 2001 Oct; 49(10):1005-13. PubMed ID: 11769465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers.
    Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
    Virchows Arch; 2006 Feb; 448(2):127-34. PubMed ID: 16177881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
    Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
    Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
    Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
    Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
    Fonsatti E; Del Vecchio L; Altomonte M; Sigalotti L; Nicotra MR; Coral S; Natali PG; Maio M
    J Cell Physiol; 2001 Jul; 188(1):1-7. PubMed ID: 11382917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoglin (cd105) and S100A13 as markers of active angiogenesis in endometriosis.
    Hayrabedyan S; Kyurkchiev S; Kehayov I
    Reprod Biol; 2005 Mar; 5(1):51-67. PubMed ID: 15821778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
    Salvesen HB; Gulluoglu MG; Stefansson I; Akslen LA
    APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.
    Fonsatti E; Sigalotti L; Arslan P; Altomonte M; Maio M
    Curr Cancer Drug Targets; 2003 Dec; 3(6):427-32. PubMed ID: 14683500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies.
    Matsuno F; Haruta Y; Kondo M; Tsai H; Barcos M; Seon BK
    Clin Cancer Res; 1999 Feb; 5(2):371-82. PubMed ID: 10037187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD105 is important for angiogenesis: evidence and potential applications.
    Duff SE; Li C; Garland JM; Kumar S
    FASEB J; 2003 Jun; 17(9):984-92. PubMed ID: 12773481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin expression as a measure of microvessel density in cervical cancer.
    Brewer CA; Setterdahl JJ; Li MJ; Johnston JM; Mann JL; McAsey ME
    Obstet Gynecol; 2000 Aug; 96(2):224-8. PubMed ID: 10908767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
    Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
    Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105.
    Li C; Guo B; Bernabeu C; Kumar S
    Microsc Res Tech; 2001 Feb; 52(4):437-49. PubMed ID: 11170303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endoglin (CD105)--a target for visualization and anti-angiogenic therapy for malignant tumors].
    Smirnov IV; Gryazeva IV; Samoilovich MP; Klimovich VB
    Vopr Onkol; 2015; 61(6):898-907. PubMed ID: 26995976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.